These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6654019)

  • 1. [Manufacture of blood preservatives].
    Golubeva VL; Suvorova IA; Minina LT; Makarova EM; Demicheva MI
    Gematol Transfuziol; 1983 Oct; 28(10):58-61. PubMed ID: 6654019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Microaggregation process in blood transfusion media preserved with citroglucophosphate and glugicire and the means of decreasing its intensity].
    Petrov MM; Timchenko NV
    Gematol Transfuziol; 1983 Oct; 28(10):37-40. PubMed ID: 6654015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative characteristics of the effect of various blood preservatives on myocardial contractility].
    Iarochkin VS; Koziner VB
    Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):32-5. PubMed ID: 1025549
    [No Abstract]   [Full Text] [Related]  

  • 4. A new preservative medium containing adenine and inosine.
    NAKAO M; NAKAO T; YOSHIKAWA H; WADA T; TAKAKU H; NAKAO K
    Bibl Haematol; 1962; 13():455-61. PubMed ID: 14478204
    [No Abstract]   [Full Text] [Related]  

  • 5. [Laboratory-clinical substantiation of permissibility of blood preparation on preservatives without levomycetin].
    Petrov MM; Fedorovskaia EA; Kushko OV; Babiĭ ZN; Petrushov VN
    Probl Gematol Pereliv Krovi; 1978 May; 23(5):55-7. PubMed ID: 674150
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucose in platelet additive solutions: to add or not to add?
    Gyongyossy-Issa MI
    Transfus Apher Sci; 2011 Jun; 44(3):283-95. PubMed ID: 21493158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospects for using blood preservatives with antimicrobial properties].
    Siroko IA; Komarov EV; Zhuravlev IuN; Iudelevich VI; Rudenko NN
    Voen Med Zh; 1987 Apr; (4):19-20. PubMed ID: 3604077
    [No Abstract]   [Full Text] [Related]  

  • 8. Additive solutions for the storage of platelets for transfusion.
    Gulliksson H
    Transfus Med; 2000 Dec; 10(4):257-64. PubMed ID: 11123809
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of clinical effect of cadaveric blood, prepared with different preservatives].
    Mikhaĭlova LI; Oldurova SV; Suvorova IA; Dubrovina NA; Zamchiĭ AA
    Probl Gematol Pereliv Krovi; 1973 Dec; 18(12):8-13. PubMed ID: 4789376
    [No Abstract]   [Full Text] [Related]  

  • 10. [COMPARATIVE EVALUATION OF PRESERVATIVES TSOLIPK NO. 7 AND NO. 12 AS STABILIZERS OF THE BLOOD COAGULATION SYSTEM AND NATURAL ANTICOAGULANTS].
    KUCHUK AP
    Probl Gematol Pereliv Krovi; 1964 Aug; 9():44-9. PubMed ID: 14252417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of 2-ethyl-6-methyl-3-hydroxypyridine succinate on lipid peroxidation and antioxidant defense in erythrocytes during storage of donor erythrocyte mass].
    Zor'kina AV; Makedonskaia OG; Biakin SP; Fedoseĭkin IV; Makhrov VI
    Fiziol Cheloveka; 2009; 35(5):139-42. PubMed ID: 19899703
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative characteristics of blood prepared with No. 12 and 76 preservatives].
    Oldurova SV; Suvorova LA; Sukhova AG; Golubeva VL; Manueva GN
    Probl Gematol Pereliv Krovi; 1975 Jan; 20(1):40-3. PubMed ID: 1110962
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet storage in PAS-2 or autologous plasma: impact on functional parameters.
    Bunescu A; Hild M; Lundahl J; Egberg N
    Transfus Med; 2001 Apr; 11(2):105-10. PubMed ID: 11299027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of citrate-gelatin mixtures as routine blood preservative for blood banks.
    BROWN WO
    Am J Med Technol; 1948 Mar; 14(2):87-92. PubMed ID: 18915867
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of an anti-Pr1d cold agglutinin by citrate present in commercial red cell preservative solutions.
    Green ED; Curtis BR; Issitt PD; Gutgsell NS; Roelcke D; Farrar RP; Chaplin H
    Transfusion; 1990; 30(3):267-70. PubMed ID: 2316003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood stored in half-strength trisodium citrate.
    Mishler JM; Darley JH; Cederholm-Williams S
    Lancet; 1977 Jan; 1(8003):152. PubMed ID: 64693
    [No Abstract]   [Full Text] [Related]  

  • 17. [Expediency of including antibacterial preparations in the composition of blood preservatives].
    Dovgalev SI; Stakhovskii EV
    Voen Med Zh; 1978 Nov; (11):70-1. PubMed ID: 734942
    [No Abstract]   [Full Text] [Related]  

  • 18. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality.
    van der Meer PF; Pietersz RN; Reesink HW
    Transfusion; 2004 Aug; 44(8):1204-11. PubMed ID: 15265125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrate-phosphate-dextrose solution for preservation of human blood: a further report.
    GIBSON JG; GREGORY CB; BUTTON LN
    Transfusion; 1961; 1():280-7. PubMed ID: 13705121
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to H. Ohto and K.E. Nollet article entitled 'Overview on platelet preservation: better controls over storage lesion', Transfusion and Apheresis Science 44(2011) 321-325.
    Badlou BA
    Transfus Apher Sci; 2012 Feb; 46(1):105-6; author reply 107. PubMed ID: 22015251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.